168 related articles for article (PubMed ID: 27458870)
1. Bioengineering of differentiated hepatocytes with human factor IX-expressing plasmids in vitro.
Azadbakhsh AS; Sam MR; Farokhi F
Bioengineered; 2016 Nov; 7(6):497-503. PubMed ID: 27458870
[TBL] [Abstract][Full Text] [Related]
2. A systematic study of the function of the human beta-globin introns on the expression of the human coagulation factor IX in cultured Chinese hamster ovary cells.
Haddad-Mashadrizeh A; Zomorodipour A; Izadpanah M; Sam MR; Ataei F; Sabouni F; Hosseini SJ
J Gene Med; 2009 Oct; 11(10):941-50. PubMed ID: 19565465
[TBL] [Abstract][Full Text] [Related]
3. Genetic modification of bone-marrow mesenchymal stem cells and hematopoietic cells with human coagulation factor IX-expressing plasmids.
Sam MR; Azadbakhsh AS; Farokhi F; Rezazadeh K; Sam S; Zomorodipour A; Haddad-Mashadrizeh A; Delirezh N; Mokarizadeh A
Biologicals; 2016 May; 44(3):170-7. PubMed ID: 26928674
[TBL] [Abstract][Full Text] [Related]
4. Functions of the Heterologous Intron-Derived Fragments Intra and Extra Factor IX-cDNA Coding Region on the Human Factor IX Expression in HepG2 and Hek-293T Cells.
Sam MR; Zomorodipour A; Haddad-Mashadrizeh A; Ghorbani M; Kardar GA; Sam S
Iran J Biotechnol; 2018 May; 16(2):e1753. PubMed ID: 30805387
[TBL] [Abstract][Full Text] [Related]
5. Enhancement of the human factor IX expression, mediated by an intron derived fragment from the rat aldolase B gene in cultured hepatoma cells.
Sam MR; Zomorodipour A; Shokrgozar MA; Ataei F; Haddad-Mashadrizeh A; Amanzadeh A
Biotechnol Lett; 2010 Oct; 32(10):1385-92. PubMed ID: 20559684
[TBL] [Abstract][Full Text] [Related]
6. Long-term and therapeutic-level hepatic gene expression of human factor IX after naked plasmid transfer in vivo.
Miao CH; Thompson AR; Loeb K; Ye X
Mol Ther; 2001 Jun; 3(6):947-57. PubMed ID: 11407909
[TBL] [Abstract][Full Text] [Related]
7. Inclusion of the hepatic locus control region, an intron, and untranslated region increases and stabilizes hepatic factor IX gene expression in vivo but not in vitro.
Miao CH; Ohashi K; Patijn GA; Meuse L; Ye X; Thompson AR; Kay MA
Mol Ther; 2000 Jun; 1(6):522-32. PubMed ID: 10933977
[TBL] [Abstract][Full Text] [Related]
8. Efficient expression of functional human coagulation factor IX in stably-transfected Drosophila melanogaster S2 cells; comparison with the mammalian CHO system.
Vatandoost J; Bos MH
Biotechnol Lett; 2016 Oct; 38(10):1691-8. PubMed ID: 27565667
[TBL] [Abstract][Full Text] [Related]
9. Construction of human factor IX expression vectors in retroviral vector frames optimized for muscle cells.
Wang JM; Zheng H; Sugahara Y; Tan J; Yao SN; Olson E; Kurachi K
Hum Gene Ther; 1996 Sep; 7(14):1743-56. PubMed ID: 8886845
[TBL] [Abstract][Full Text] [Related]
10. Complete and sustained phenotypic correction of hemophilia B in mice following hepatic gene transfer of a high-expressing human factor IX plasmid.
Ye X; Loeb KR; Stafford DW; Thompson AR; Miao CH
J Thromb Haemost; 2003 Jan; 1(1):103-11. PubMed ID: 12871546
[TBL] [Abstract][Full Text] [Related]
11. A new potent hFIX plasmid for hemophilia B gene therapy.
Lee JS; Lee M; Kim SW
Pharm Res; 2004 Jul; 21(7):1229-32. PubMed ID: 15290864
[TBL] [Abstract][Full Text] [Related]
12. Gene therapy for hemophilia B with liver-specific element mediated by Rep-RBE site-specific integration system.
Xu Z; Ye J; Zhang A; Xie L; Shen Q; Xue J; Chen J
J Cardiovasc Pharmacol; 2015 Feb; 65(2):153-9. PubMed ID: 25295466
[TBL] [Abstract][Full Text] [Related]
13. A study of the expression of functional human coagulation factor IX in keratinocytes using a nonviral vector regulated by K14 promoter.
Hosseini SJ; Zomorodipour A; Jalal R; Sabouni F; Ataei F
Appl Biochem Biotechnol; 2010 Nov; 162(6):1599-611. PubMed ID: 20397061
[TBL] [Abstract][Full Text] [Related]
14. Expression of biologically active human clotting factor IX in Drosophila S2 cells: γ-carboxylation of a human vitamin K-dependent protein by the insect enzyme.
Vatandoost J; Zomorodipour A; Sadeghizadeh M; Aliyari R; Bos MH; Ataei F
Biotechnol Prog; 2012; 28(1):45-51. PubMed ID: 22012919
[TBL] [Abstract][Full Text] [Related]
15. Optimized human factor IX expression cassettes for hepatic-directed gene therapy of hemophilia B.
Zhang R; Wang Q; Zhang L; Chen S
Front Med; 2015 Mar; 9(1):90-9. PubMed ID: 25663062
[TBL] [Abstract][Full Text] [Related]
16. Regulation of human factor IX expression using doxycycline-inducible gene expression system.
Srour MA; Fechner H; Wang X; Siemetzki U; Albert T; Oldenburg J; Hanfland P; Poller W; Brackmann HH; Schwaab R
Thromb Haemost; 2003 Sep; 90(3):398-405. PubMed ID: 12958607
[TBL] [Abstract][Full Text] [Related]
17. [Expression of human factor IX in retrovirus-transfected human umbilical cord tissue derived mesenchymal stem cells].
Chen XL; Dong CL; Feng XM; Chen ZP; Zhou ZP; Xu XH; Zhao QJ; Qiu ZY; Ren Q; Zhang L; Han ZC
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2009 Feb; 17(1):184-7. PubMed ID: 19236775
[TBL] [Abstract][Full Text] [Related]
18. [Preparation of rAAV2/hFIX and experimentally application to gene therapy for hemophilia B].
Peng JQ; Dong XY; Peng M; Chen L; Tan SP; Yuan H; Chen FP; Xue JL; Wu XB
Zhonghua Xue Ye Xue Za Zhi; 2004 Sep; 25(9):513-8. PubMed ID: 15569526
[TBL] [Abstract][Full Text] [Related]
19. Effects of a second intron on recombinant MFG retroviral vector.
Malik AK; Wang JM; Kurachi K
Arch Virol; 2001; 146(3):601-9. PubMed ID: 11338393
[TBL] [Abstract][Full Text] [Related]
20. Increment of hFIX expression with endogenous intron 1 in vitro.
Zheng B; Qiu XY; Tan M; Xing YN; Lo D; Xue JL; Qiu XF
Cell Res; 1997 Jun; 7(1):21-9. PubMed ID: 9261559
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
